The first efficacy trials--named STEP--of a T cell vaccine against HIV/AIDS began in 2004. The unprecedented structure of these trials raised new modeling and statistical challenges. Is it plausible that memory T cells. as opposed to antibodies. https://www.roneverhart.com/Tasoliesi-Hackman-RTL-6-levyinen-15kW/